S&CO Inc
- SEC CIK
- 0001082461
- Latest filing
- Aug 6, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by S&CO Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,400
- Value
- $2.23M
- % of portfolio
- 0.1%
- Quarters held
- 10
- Since Q1 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,400 | $2.23M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 7,400 | $2.45M | 0.2% | −800−9.8% | Reduced | Holders |
| Q4 2025 | 8,200 | $3.26M | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2025 | 8,200 | $3.74M | 0.2% | −1,850−18.4% | Reduced | Holders |
| Q2 2025 | 10,050 | $3.28M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 10,050 | $2.71M | 0.2% | +4,300+74.8% | Added | Holders |
| Q4 2024 | 5,750 | $1.35M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 5,750 | $1.58M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 5,750 | $1.40M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 5,750 | $859.0K | 0.1% | +5,750 | New | Holders |